Sponsor

LiteVax B.V.

The Netherlands Akkersestraat 50, 4061 BJ, The Netherlands

About the sponsor

LiteVax B.V. conducts clinical research in influenza vaccine development, with attention to safety, tolerability, and immunogenicity in healthy adults across different age groups.

Adjuvanted influenza vaccines
Healthy adult immunisation
Age-related immune responses

The sponsor’s influenza programme includes interest in vaccine formulations designed to enhance immune responses while maintaining acceptable tolerability.

About Specializations

LiteVax B.V. runs clinical trials in conditions such as Influenza, among others.

Influenza

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Quick filters

1 clinical trial

Influenza

Not recruiting

Registered drugNo placebo

A Study to Test the Safety and Body's Response to TETRALITE Influenza Vaccine Compared to Vaxigrip Tetra Vaccine in Healthy Adults Aged 18 to 50 Years

Registered drugNo placebo

Belgium

Participants:18–64 years · Healthy volunteers
Substances:A/Victoria/2570/2019 (H1N1)Pdm09-Like Strain (A/Victoria/2570/2019, Ivr-215)
Sponsor:LiteVax B.V.

Contact Research Centre

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →